Meta-analysis of the safety and tolerabi
β
John J. Sramek; Walter W. Hong; Suha Hamid; Barbara Nape; Neal R. Cutler
π
Article
π
1999
π
John Wiley and Sons
π
English
β 57 KB
π 1 views
Buspirone is an azapirone with 5-HT 1A partial agonist activity which has demonstrated efficacy in the treatment of generalized anxiety disorder, commonly referred to as persistent anxiety. In this meta-analysis report, safety results from two studies comparing buspirone 15 mg twice daily (BID) with